Table 4.
Logistic regression analysis of factors associated with carbapenem-resistant gram-negative bacterial bloodstream infection in cancer patients
| n (%) | n (%) | Univariate | p-value | |
|---|---|---|---|---|
| Age | ||||
| < 60 | 78 (83) | 54(56.8) | 3.701 (1.887,7.262) | < 0.0001 |
| > 60* | 16 (17) | 41(43.2) | ||
| Malignancy type | ||||
| Solid organ | 55 (58.5) | 35 (36.8) | 2.418 (1.347,4.339) | 0.003 |
| Hematologic malignancy* | 39 (41.5) | 60 (63.2) | ||
| Enterobacterales | ||||
| Yes* | 33 (35.1) | 81 (85.3) | 10.695 (5.269,21.709) | < 0.0001 |
| No | 61 (64.9) | 14 (14.7) | ||
| 4th GCRGN | ||||
| Resistance | 42 (44.7) | 31 (32.6) | 1.667 (0.923,3.011) | 0.090 |
| Sensitive* | 52 (55.3) | 64 (67.4) | ||
| 3rd GCRGN | ||||
| Resistance | 88 (93.6) | 57 (60) | 9.778 (3.884,24.615) | < 0.0001 |
| Sensitive* | 6 (6.4) | 38 (40) | ||
| Aminoglycoside-resistant | ||||
| Resistance | 31 (33) | 21 (22.1) | 1.734 (0.907,3.314) | 0.096 |
| Sensitive* | 63 (67) | 74 (77.9) | ||
| Polymyxin-resistance | ||||
| Resistance | 50 (53.2) | 6 (6.3) | 16.856 (6.713,42.323) | < 0.0001 |
| Sensitive* | 44 (46.8) | 89 (93.7) | ||
* Reference. P-values marked with bold indicate statistically significant p-values